Search results | NICE

5 results

Sorted by Relevance . Sort by Date

NICE advice Remove NICE advice filter
Indicators Remove Indicators filter
NICE Pathways Remove NICE Pathways filter
Local practice Remove Local practice filter
Last 6 months Remove Last 6 months filter
Evidence summaries Remove Evidence summaries filter

Antimicrobial prescribing: delafloxacin for acute bacterial skin and skin structure infections (ES32)

Summary of the evidence on antimicrobial prescribing: delafloxacin

Type

Evidence summary: antimicrobial prescribing

Published

05 January 2021
COVID-19 rapid evidence summary: Tocilizumab for COVID-19 (ES33)

ES33 Product overview The content of this evidence summary was up to date in January 2021. See summaries of product characteristics

Type

Evidence summary: COVID-19 rapid summary

Published

15 January 2021
COVID-19 rapid evidence summary: Sarilumab for COVID-19 (ES34)

ES34 Product overview The content of this evidence summary was up to date in January 2021. See summaries of product characteristics

Type

Evidence summary: COVID-19 rapid summary

Published

20 January 2021
Antimicrobial prescribing: imipenem with cilastatin and relebactam (ES30)

Summary of the evidence on antimicrobial prescribing: imipenem with cilastatin and relebactam

Type

Evidence summary: antimicrobial prescribing

Published

28 October 2020
Antimicrobial prescribing: cefiderocol (ES31)

Summary of the evidence on antimicrobial prescribing: cefiderocol

Type

Evidence summary: antimicrobial prescribing

Published

02 December 2020